Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis

Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hinde...

Full description

Saved in:
Bibliographic Details
Published in:Drug design, development and therapy Vol. 16; pp. 2365 - 2382
Main Authors: Yang, Fei-Ran, Li, Si-Yi, Hu, Xi-Wen, Li, Xiu-Rong, Li, Hui-Jie
Format: Journal Article
Language:English
Published: Macclesfield Dove Medical Press Limited 01-01-2022
Taylor & Francis Ltd
Dove
Dove Medical Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Materials and Methods: LUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein-protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells. Results: In this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes. Conclusion: The results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment. Keywords: lung adenocarcinoma, curcumin, antitumor effect, bioinformatics analysis, TCGA
AbstractList BackgroundAs the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Materials and MethodsLUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein-protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells. ResultsIn this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes. ConclusionThe results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment.
Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin.
Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Materials and Methods: LUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein-protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells. Results: In this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes. Conclusion: The results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment. Keywords: lung adenocarcinoma, curcumin, antitumor effect, bioinformatics analysis, TCGA
Fei-Ran Yang,1,* Si-Yi Li,1,* Xi-Wen Hu,1 Xiu-Rong Li,2 Hui-Jie Li2 1College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China; 2Department of Oncology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hui-Jie Li; Xiu-Rong Li, Department of Oncology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jingshi Road, Jinan, Shandong, 250014, People’s Republic of China, Email 2008lihuijie@163.com; szylxr2012@126.comBackground: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin.Materials and Methods: LUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein–protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells.Results: In this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes.Conclusion: The results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment.Graphical Abstract: Keywords: lung adenocarcinoma, curcumin, antitumor effect, bioinformatics analysis, TCGA
Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Materials and Methods: LUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein–protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells. Results: In this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes. Conclusion: The results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment. Graphical Abstract:
Audience Academic
Author Hu, Xi-Wen
Li, Xiu-Rong
Li, Si-Yi
Yang, Fei-Ran
Li, Hui-Jie
Author_xml – sequence: 1
  fullname: Yang, Fei-Ran
– sequence: 2
  fullname: Li, Si-Yi
– sequence: 3
  fullname: Hu, Xi-Wen
– sequence: 4
  fullname: Li, Xiu-Rong
– sequence: 5
  fullname: Li, Hui-Jie
BookMark eNptkk9v0zAYhyM0xLbCjQ8QCQlxoMWO_yUXpK4dUKkSB7az5TivG1eJXexkUr89Dq1gRSiHxM7zPol_-t1mV847yLK3GC0KTMWn9Xr9sPhBBKYFepHdYCzEvCxLfPXs-Tq7jXGPECe8QK-ya8IqjESJb7LDpgE3WHO0bpcPLeTLtBrG3of83hjQQ8y9yVdj0GNvXe5dvh0TuUxTXqugrfO9yh_jNL7y_SFACy7aJ8jvrLfO-NCrweqYvKo7RhtfZy-N6iK8Od9n2eOX-4fVt_n2-9fNarmda8bIMBekqGvcINQIQiulKQONNDBEac0FUcxg3ugEGFoUFSoFaFUQpEvKjGYcyCzbnLyNV3t5CLZX4Si9svL3hg87qUL6sw4krRky0BhOMaNMM5XCLE2tsQKkRUOT6_PJdRjrHhqdEguqu5BevnG2lTv_JCtSVLwskuDDWRD8zxHiIHsbNXSdcuDHKAteCVRxnk42y979g-79GFJ4iRKIYF5VmPyldiodYMo5fVdPUrlMTUgeJCZq8R8qXQ30VqcaGZv2LwbePxtoQXVDG303Dta7eAl-PIE6-BgDmD9hYCSnWsqplvJcS_ILUe_UwA
CitedBy_id crossref_primary_10_1016_j_jep_2023_116565
crossref_primary_10_1111_1759_7714_15121
crossref_primary_10_1021_acsabm_3c01145
crossref_primary_10_1007_s11101_023_09894_9
Cites_doi 10.1007/s40618-016-0508-7
10.1007/978-1-59745-177-2_19
10.1158/0008-5472.CAN-14-2317
10.1016/j.cell.2018.02.052
10.1038/nature11412
10.1007/s10822-007-9114-2
10.1007/s11626-014-9779-5
10.1371/journal.pone.0171628
10.1016/j.nutres.2014.09.001
10.5604/01.3001.0010.5273
10.1158/0008-5472.CAN-12-3385
10.1016/j.jcte.2018.12.005
10.3322/caac.21235
10.3389/fendo.2019.00481
10.1056/NEJMra1703413
10.3390/ijms13033959
10.1200/JCO.2007.13.9030
10.3389/fonc.2014.00204
10.1016/j.jff.2015.01.005
10.1016/j.ejca.2018.11.002
10.5114/wo.2014.47136
10.1530/ERC-11-0374
10.1093/bioinformatics/bts251
10.1002/ptr.6422
10.1371/journal.pone.0083922
10.1021/jm020406h
10.1371/journal.pone.0099317
10.1111/cpr.12575
10.1155/2013/239354
10.1210/me.2010-0120
10.1007/s00018-008-8281-1
10.1016/j.lfs.2016.02.022
10.1016/j.biosystems.2014.11.005
10.3390/ijms20184606
10.1080/10408398.2018.1552244
10.3892/ijo.2015.2865
10.1007/s10549-016-4013-7
10.1111/apt.12092
10.1016/0002-9610(85)90406-4
10.1002/JLB.3MR0320-444R
10.1093/nar/gks1094
10.2174/1389450119666181022153016
10.1159/000440941
10.1158/0008-5472.CAN-07-6734
10.1002/jat.2814
10.1016/j.gene.2021.145666
10.1002/ptr.6620
10.1002/ptr.6037
10.1016/j.phymed.2019.152893
10.1039/D1FO02002A
10.1126/science.1141478
10.1007/s10552-015-0613-5
10.3892/ijo.2012.1480
10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.0.CO;2-C
10.1155/2012/789174
10.1158/1078-0432.CCR-07-4495
10.1080/22221751.2020.1719902
10.2147/JEP.S70568
10.2174/1381612823666170622105123
10.1016/j.jtho.2017.08.008
10.1186/1471-2105-4-2
10.1038/nrendo.2015.51
10.18632/oncotarget.24367
10.1038/nrc3775
10.1016/j.jnutbio.2013.11.001
10.3892/or.2015.4258
10.1016/j.bmc.2017.01.043
10.1023/A:1011980313237
10.1016/j.phrs.2017.03.001
10.1038/nm.3391
10.3322/caac.21551
10.3892/ol.2015.3324
ContentType Journal Article
Copyright COPYRIGHT 2022 Dove Medical Press Limited
2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 Yang et al. 2022 Yang et al.
Copyright_xml – notice: COPYRIGHT 2022 Dove Medical Press Limited
– notice: 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 Yang et al. 2022 Yang et al.
DBID AAYXX
CITATION
3V.
7QO
7RV
7XB
8FD
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
KB0
M2O
MBDVC
NAPCQ
P64
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.2147/DDDT.S371420
DatabaseName CrossRef
ProQuest Central (Corporate)
Biotechnology Research Abstracts
ProQuest Nursing & Allied Health Database
ProQuest Central (purchase pre-March 2016)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
Nursing & Allied Health Database (Alumni Edition)
ProQuest research library
Research Library (Corporate)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database (Proquest) (PQ_SDU_P3)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Biotechnology Research Abstracts
ProQuest Central Korea
ProQuest Research Library
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Yang et al
EISSN 1177-8881
EndPage 2382
ExternalDocumentID oai_doaj_org_article_4b50fedf641545c5a3718fbc1ae0c7d4
A714673073
10_2147_DDDT_S371420
GeographicLocations China
United States--US
GeographicLocations_xml – name: China
– name: United States--US
GrantInformation_xml – fundername: ;
GroupedDBID ---
0YH
29G
2WC
53G
5GY
5VS
7RV
8FI
8FJ
8G5
AAYXX
ABUWG
ACGFO
ACIWK
ACPRK
ADBBV
ADRAZ
AENEX
AFKRA
AFRAH
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BKEYQ
BPHCQ
BVXVI
C1A
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
EMOBN
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HYE
IAO
IHR
IHW
INH
INR
IPNFZ
ITC
KQ8
M2O
M48
MK0
M~E
NAPCQ
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RPM
SV3
TDBHL
TR2
UKHRP
VDV
3V.
7QO
7XB
8FD
8FK
COVID
FR3
MBDVC
P64
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c553t-732bb1d00d7349ac45ec0ce5044b673a5f16dc1d0f4229087eca230c845fc56e3
IEDL.DBID RPM
ISSN 1177-8881
IngestDate Tue Oct 22 15:15:13 EDT 2024
Tue Sep 17 21:24:08 EDT 2024
Fri Aug 16 22:14:39 EDT 2024
Thu Oct 10 22:02:13 EDT 2024
Tue Nov 19 21:12:01 EST 2024
Tue Nov 12 23:01:12 EST 2024
Tue Aug 20 22:12:03 EDT 2024
Fri Aug 23 01:22:12 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c553t-732bb1d00d7349ac45ec0ce5044b673a5f16dc1d0f4229087eca230c845fc56e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work
ORCID 0000-0001-8483-9337
0000-0001-8560-4951
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329682/
PMID 35910781
PQID 2703169913
PQPubID 2046454
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_4b50fedf641545c5a3718fbc1ae0c7d4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9329682
proquest_miscellaneous_2697096667
proquest_journals_2703169913
gale_infotracmisc_A714673073
gale_infotracacademiconefile_A714673073
gale_healthsolutions_A714673073
crossref_primary_10_2147_DDDT_S371420
PublicationCentury 2000
PublicationDate 2022-01-01
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Macclesfield
PublicationPlace_xml – name: Macclesfield
PublicationTitle Drug design, development and therapy
PublicationYear 2022
Publisher Dove Medical Press Limited
Taylor & Francis Ltd
Dove
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Taylor & Francis Ltd
– name: Dove
– name: Dove Medical Press
References Gunter (ref73) 2015; 75
Chen (ref50) 2008; 68
Parekh (ref62) 2015; 26
Liu (ref22) 2018; 173
Jin (ref40) 2015; 34
Wang (ref58) 2019; 52
Jiao (ref24) 2012; 28
Mantzorou (ref18) 2018; 32
Ye (ref42) 2012; 13
Hsin (ref29) 2013; 8
Janssen (ref63) 2013; 37
Morris (ref53) 2008; 443
Siegel (ref1) 2019; 69
Wan (ref6) 2013; 19
Engelman (ref43) 2007; 316
Korpanty (ref7) 2014; 4
Vallianou (ref38) 2015; 35
Zhang (ref39) 2013; 33
Hernandez (ref74) 2014; 9
Jiang (ref17) 2017; 119
Um (ref37) 2014; 34
Adeva-Andany (ref68) 2019; 15
Rodríguez Castaño (ref49) 2019; 20
Yagi (ref67) 2018; 9
Lánczky (ref28) 2016; 160
Jain (ref32) 2003; 46
DeSantis (ref4) 2014; 64
Pignon (ref3) 2008; 26
David (ref33) 2017; 12
Kumar (ref20) 2016; 148
Arcidiacono (ref60) 2012; 2012
Reuveni (ref57) 2013; 73
Panda (ref19) 2017; 9
Weichhaus (ref71) 2012; 41
Vivacqua (ref69) 2017; 23
Moyer (ref66) 1985; 150
Vigneri (ref70) 2016; 39
Sahebkar (ref36) 2015; 18
Chen (ref2) 2014; 14
Prasad (ref21) 2008; 14
Ichiki (ref14) 2000; 18
Nouri-Vaskeh (ref16) 2020; 34
Shiozaki (ref48) 1996; 77
Zhang (ref52) 2017; 12
Sarkar (ref59) 2019; 10
Saikia (ref54) 2019; 20
Cohen (ref72) 2012; 19
Koboldt (ref35) 2012; 490
Lu (ref41) 2014; 50
Yang (ref31) 2021; 788
Wattanathamsan (ref9) 2019; 33
Jain (ref30) 2007; 21
Chan (ref51) 2020; 9
Argilés (ref61) 2001; 18
Reck (ref5) 2017; 377
Campbell (ref64) 2015; 11
Hancock (ref65) 2010; 24
Tunc (ref13) 2017; 25
Matyszewski (ref55) 2015; 10
Matyszewski (ref56) 2015; 46
van Roy (ref47) 2008; 65
Kang (ref34) 2016; 61
Hu (ref12) 2017; 16
Tomczak (ref23) 2015; 19
Prelaj (ref8) 2019; 106
Liang (ref44) 2021; 12
Deng (ref11) 2020; 108
Ahsan (ref45) 2013; 2013
Franceschini (ref25) 2013; 41
Lin (ref10) 2019; 58
Patel (ref15) 2020; 60
Jiang (ref46) 2014; 25
Tang (ref27) 2015; 127
Bader (ref26) 2003; 4
References_xml – volume: 35
  start-page: 645
  year: 2015
  ident: ref38
  publication-title: Anticancer Res
  contributor:
    fullname: Vallianou
– volume: 39
  start-page: 1365
  year: 2016
  ident: ref70
  publication-title: J Endocrinol Invest
  doi: 10.1007/s40618-016-0508-7
  contributor:
    fullname: Vigneri
– volume: 443
  start-page: 365
  year: 2008
  ident: ref53
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-59745-177-2_19
  contributor:
    fullname: Morris
– volume: 75
  start-page: 270
  year: 2015
  ident: ref73
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-2317
  contributor:
    fullname: Gunter
– volume: 173
  start-page: 400
  year: 2018
  ident: ref22
  publication-title: Cell
  doi: 10.1016/j.cell.2018.02.052
  contributor:
    fullname: Liu
– volume: 490
  start-page: 61
  year: 2012
  ident: ref35
  publication-title: Nature
  doi: 10.1038/nature11412
  contributor:
    fullname: Koboldt
– volume: 21
  start-page: 281
  year: 2007
  ident: ref30
  publication-title: J Comput Aided Mol Des
  doi: 10.1007/s10822-007-9114-2
  contributor:
    fullname: Jain
– volume: 50
  start-page: 840
  year: 2014
  ident: ref41
  publication-title: In Vitro Cell Dev Biol Anim
  doi: 10.1007/s11626-014-9779-5
  contributor:
    fullname: Lu
– volume: 12
  start-page: e0171628
  year: 2017
  ident: ref52
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0171628
  contributor:
    fullname: Zhang
– volume: 34
  start-page: 886
  year: 2014
  ident: ref37
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2014.09.001
  contributor:
    fullname: Um
– volume: 16
  start-page: 835
  year: 2017
  ident: ref12
  publication-title: Ann Hepatol
  doi: 10.5604/01.3001.0010.5273
  contributor:
    fullname: Hu
– volume: 73
  start-page: 4383
  year: 2013
  ident: ref57
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-3385
  contributor:
    fullname: Reuveni
– volume: 15
  start-page: 45
  year: 2019
  ident: ref68
  publication-title: J Clin Transl Endocrinol
  doi: 10.1016/j.jcte.2018.12.005
  contributor:
    fullname: Adeva-Andany
– volume: 64
  start-page: 252
  year: 2014
  ident: ref4
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21235
  contributor:
    fullname: DeSantis
– volume: 10
  start-page: 481
  year: 2019
  ident: ref59
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2019.00481
  contributor:
    fullname: Sarkar
– volume: 377
  start-page: 849
  year: 2017
  ident: ref5
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1703413
  contributor:
    fullname: Reck
– volume: 13
  start-page: 3959
  year: 2012
  ident: ref42
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms13033959
  contributor:
    fullname: Ye
– volume: 26
  start-page: 3552
  year: 2008
  ident: ref3
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.13.9030
  contributor:
    fullname: Pignon
– volume: 4
  start-page: 204
  year: 2014
  ident: ref7
  publication-title: Front Oncol
  doi: 10.3389/fonc.2014.00204
  contributor:
    fullname: Korpanty
– volume: 18
  start-page: 898
  year: 2015
  ident: ref36
  publication-title: J Funct Foods
  doi: 10.1016/j.jff.2015.01.005
  contributor:
    fullname: Sahebkar
– volume: 106
  start-page: 144
  year: 2019
  ident: ref8
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2018.11.002
  contributor:
    fullname: Prelaj
– volume: 19
  start-page: A68
  year: 2015
  ident: ref23
  publication-title: Contemp Oncol
  doi: 10.5114/wo.2014.47136
  contributor:
    fullname: Tomczak
– volume: 19
  start-page: F27
  year: 2012
  ident: ref72
  publication-title: Endocr Relat Cancer
  doi: 10.1530/ERC-11-0374
  contributor:
    fullname: Cohen
– volume: 28
  start-page: 1805
  year: 2012
  ident: ref24
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bts251
  contributor:
    fullname: Jiao
– volume: 18
  start-page: 683
  year: 2001
  ident: ref61
  publication-title: Int J Oncol
  contributor:
    fullname: Argilés
– volume: 33
  start-page: 2531
  year: 2019
  ident: ref9
  publication-title: Phytother Res
  doi: 10.1002/ptr.6422
  contributor:
    fullname: Wattanathamsan
– volume: 8
  start-page: e83922
  year: 2013
  ident: ref29
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0083922
  contributor:
    fullname: Hsin
– volume: 46
  start-page: 499
  year: 2003
  ident: ref32
  publication-title: J Med Chem
  doi: 10.1021/jm020406h
  contributor:
    fullname: Jain
– volume: 9
  start-page: e99317
  year: 2014
  ident: ref74
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0099317
  contributor:
    fullname: Hernandez
– volume: 52
  start-page: e12575
  year: 2019
  ident: ref58
  publication-title: Cell Prolif
  doi: 10.1111/cpr.12575
  contributor:
    fullname: Wang
– volume: 2013
  start-page: 239354
  year: 2013
  ident: ref45
  publication-title: Biomed Res Int
  doi: 10.1155/2013/239354
  contributor:
    fullname: Ahsan
– volume: 24
  start-page: 1605
  year: 2010
  ident: ref65
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2010-0120
  contributor:
    fullname: Hancock
– volume: 65
  start-page: 3756
  year: 2008
  ident: ref47
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-008-8281-1
  contributor:
    fullname: van Roy
– volume: 148
  start-page: 313
  year: 2016
  ident: ref20
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2016.02.022
  contributor:
    fullname: Kumar
– volume: 127
  start-page: 67
  year: 2015
  ident: ref27
  publication-title: Bio Syst
  doi: 10.1016/j.biosystems.2014.11.005
  contributor:
    fullname: Tang
– volume: 20
  start-page: 4606
  year: 2019
  ident: ref49
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20184606
  contributor:
    fullname: Rodríguez Castaño
– volume: 60
  start-page: 887
  year: 2020
  ident: ref15
  publication-title: Crit Rev Food Sci Nutr
  doi: 10.1080/10408398.2018.1552244
  contributor:
    fullname: Patel
– volume: 46
  start-page: 1435
  year: 2015
  ident: ref56
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2015.2865
  contributor:
    fullname: Matyszewski
– volume: 160
  start-page: 439
  year: 2016
  ident: ref28
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-016-4013-7
  contributor:
    fullname: Lánczky
– volume: 37
  start-page: 18
  year: 2013
  ident: ref63
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.12092
  contributor:
    fullname: Janssen
– volume: 150
  start-page: 676
  year: 1985
  ident: ref66
  publication-title: Am J Surg
  doi: 10.1016/0002-9610(85)90406-4
  contributor:
    fullname: Moyer
– volume: 108
  start-page: 493
  year: 2020
  ident: ref11
  publication-title: J Leukoc Biol
  doi: 10.1002/JLB.3MR0320-444R
  contributor:
    fullname: Deng
– volume: 41
  start-page: D808
  year: 2013
  ident: ref25
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gks1094
  contributor:
    fullname: Franceschini
– volume: 20
  start-page: 501
  year: 2019
  ident: ref54
  publication-title: Curr Drug Targets
  doi: 10.2174/1389450119666181022153016
  contributor:
    fullname: Saikia
– volume: 61
  start-page: 41
  year: 2016
  ident: ref34
  publication-title: Chemotherapy
  doi: 10.1159/000440941
  contributor:
    fullname: Kang
– volume: 68
  start-page: 7428
  year: 2008
  ident: ref50
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6734
  contributor:
    fullname: Chen
– volume: 33
  start-page: 1468
  year: 2013
  ident: ref39
  publication-title: J Appl Toxicol
  doi: 10.1002/jat.2814
  contributor:
    fullname: Zhang
– volume: 788
  start-page: 145666
  year: 2021
  ident: ref31
  publication-title: Gene
  doi: 10.1016/j.gene.2021.145666
  contributor:
    fullname: Yang
– volume: 34
  start-page: 1446
  year: 2020
  ident: ref16
  publication-title: Phytother Res
  doi: 10.1002/ptr.6620
  contributor:
    fullname: Nouri-Vaskeh
– volume: 32
  start-page: 957
  year: 2018
  ident: ref18
  publication-title: Phytother Res
  doi: 10.1002/ptr.6037
  contributor:
    fullname: Mantzorou
– volume: 58
  start-page: 152893
  year: 2019
  ident: ref10
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2019.152893
  contributor:
    fullname: Lin
– volume: 12
  start-page: 10667
  year: 2021
  ident: ref44
  publication-title: Food Funct
  doi: 10.1039/D1FO02002A
  contributor:
    fullname: Liang
– volume: 316
  start-page: 1039
  year: 2007
  ident: ref43
  publication-title: Science
  doi: 10.1126/science.1141478
  contributor:
    fullname: Engelman
– volume: 26
  start-page: 1189
  year: 2015
  ident: ref62
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-015-0613-5
  contributor:
    fullname: Parekh
– volume: 41
  start-page: 745
  year: 2012
  ident: ref71
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2012.1480
  contributor:
    fullname: Weichhaus
– volume: 77
  start-page: 1605
  year: 1996
  ident: ref48
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.0.CO;2-C
  contributor:
    fullname: Shiozaki
– volume: 2012
  start-page: 789174
  year: 2012
  ident: ref60
  publication-title: Exp Diabetes Res
  doi: 10.1155/2012/789174
  contributor:
    fullname: Arcidiacono
– volume: 14
  start-page: 3327
  year: 2008
  ident: ref21
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-4495
  contributor:
    fullname: Prasad
– volume: 9
  start-page: 221
  year: 2020
  ident: ref51
  publication-title: Emerg Microbes Infect
  doi: 10.1080/22221751.2020.1719902
  contributor:
    fullname: Chan
– volume: 9
  start-page: 31
  year: 2017
  ident: ref19
  publication-title: J Exp Pharmacol
  doi: 10.2147/JEP.S70568
  contributor:
    fullname: Panda
– volume: 23
  start-page: 3658
  year: 2017
  ident: ref69
  publication-title: Curr Pharm Des
  doi: 10.2174/1381612823666170622105123
  contributor:
    fullname: Vivacqua
– volume: 12
  start-page: 1636
  year: 2017
  ident: ref33
  publication-title: J Thoracic Oncol
  doi: 10.1016/j.jtho.2017.08.008
  contributor:
    fullname: David
– volume: 4
  start-page: 2
  year: 2003
  ident: ref26
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-4-2
  contributor:
    fullname: Bader
– volume: 11
  start-page: 329
  year: 2015
  ident: ref64
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2015.51
  contributor:
    fullname: Campbell
– volume: 9
  start-page: 10650
  year: 2018
  ident: ref67
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24367
  contributor:
    fullname: Yagi
– volume: 14
  start-page: 535
  year: 2014
  ident: ref2
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3775
  contributor:
    fullname: Chen
– volume: 25
  start-page: 241
  year: 2014
  ident: ref46
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2013.11.001
  contributor:
    fullname: Jiang
– volume: 34
  start-page: 2782
  year: 2015
  ident: ref40
  publication-title: Oncol Rep
  doi: 10.3892/or.2015.4258
  contributor:
    fullname: Jin
– volume: 25
  start-page: 1717
  year: 2017
  ident: ref13
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2017.01.043
  contributor:
    fullname: Tunc
– volume: 18
  start-page: 539
  year: 2000
  ident: ref14
  publication-title: Clin Exp Metastasis
  doi: 10.1023/A:1011980313237
  contributor:
    fullname: Ichiki
– volume: 119
  start-page: 373
  year: 2017
  ident: ref17
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2017.03.001
  contributor:
    fullname: Jiang
– volume: 19
  start-page: 1450
  year: 2013
  ident: ref6
  publication-title: Nat Med
  doi: 10.1038/nm.3391
  contributor:
    fullname: Wan
– volume: 69
  start-page: 7
  year: 2019
  ident: ref1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21551
  contributor:
    fullname: Siegel
– volume: 10
  start-page: 589
  year: 2015
  ident: ref55
  publication-title: Oncol Lett
  doi: 10.3892/ol.2015.3324
  contributor:
    fullname: Matyszewski
SSID ssj0063620
Score 2.3266532
Snippet Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have...
Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the...
BackgroundAs the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have...
Fei-Ran Yang,1,* Si-Yi Li,1,* Xi-Wen Hu,1 Xiu-Rong Li,2 Hui-Jie Li2 1College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine,...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 2365
SubjectTerms Adenocarcinoma
Anticancer properties
Antitumor activity
antitumor effect
Apoptosis
B cells
Bioinformatics
bioinformatics analysis
Biological properties
Biomarkers
Cancer therapies
Care and treatment
Cell cycle
Cell growth
Cell proliferation
Chemical compounds
Computational biology
Computer graphics
Curcumin
Gene expression
Gene set enrichment analysis
Genes
Health aspects
Immunotherapy
Kinases
Ligands
lung adenocarcinoma
Lung cancer
Molecular docking
Natural products
Network analysis
Neuropeptide Y
Original Research
Pharmacology
Protein-protein interactions
Proteins
RNA
Software
Survival analysis
tcga
Technology application
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07b9RAEF5BKhoEAcRBCIsEoYmJvd6Xy0suUQqEIuWQ6Fb7snLF2ZEvLvLvmfH6LjEUNLTesWzvzH4zY818Q8hn5mrObFVkRfQ64875rFIiZLX1igmttK-wG_nyWv34pRfnSJOzG_WFNWGJHjht3Al3Iq9jqCVHZ--FLQFNa-cLG3OvQmICzeU2mUoYLAGW8zRWBTBY6yKVvONMnpPFYrH8do1EdTjj-5EzGjj7_0bmP6slH7mfixfk-Rg30nl635fkSWz2ydFVIp6-P6bLhz6qzTE9olcPlNT3r8ht6scdepoohHx0jt25_brtaKIv3tC2pmd95_v1qqFtQ78DCNA53AW-rvOrpl1bOpQXUESQLt6kwnd6umpH7lV8Mt1ynLwmPy_Ol2eX2ThrIfNClHeZKplzRcjzoEpeWc9F9LmPIufcSVVaURcyeBAA1bIq1yp6C9mL11zUXshYviF7TdvEt4QGG2ReKctcySHZLJwPLDAIJDWzLFg5I1-2m25uE6WGgVQElWNQOWZUzoycokZ2MkiEPVwA8zCjeZh_mceMfER9mtRVujvOZq7QRSDAzcjXQQI3C_Tr7diXAB-D1FgTyYOJJBxEP13e2owZgWBjGM4HkBCEw_Kn3TLeicVtTWx7kJGVgkxSSjUjamJrk2-frjSrm4EMHOLvSmr27n9s1nvyjGF3x_CH6YDs3XV9_ECebkJ_OByv3wkyLBo
  priority: 102
  providerName: Directory of Open Access Journals
Title Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis
URI https://www.proquest.com/docview/2703169913
https://search.proquest.com/docview/2697096667
https://pubmed.ncbi.nlm.nih.gov/PMC9329682
https://doaj.org/article/4b50fedf641545c5a3718fbc1ae0c7d4
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfYTlwQn6IwhpFgXJY2cfyRHLt20w6AKq1I3CL72WGVaFKly2H_Pc9O0hG4cY2flcTP78t6v58J-chMyZnOkyhxkEXcGIhyJWxUalBMZCqD3KORr2_Utx_Z8tLT5IgBCxOa9sFsptWv7bTa3Ibeyt0WZkOf2Gz1dYE5Ry4zNjsiR5gbDiV6534leuS463D3V_DMlsvlenrjeemYv_UtFRgfVZaMwlBg6__XJ__dJ_lH4Ll6Sp70GSOdd1_2jDxy1XNytuoop-_P6foBQbU_p2d09UBGff-C7DokbkAzUUz26Nzjcttt3dCOuHhP65Iu2gba7aaidUW_oPnTOc7CKNfApqq3mobGAup9R-Nuu5Z3erGpe9ZV_2Y6sJu8JN-vLteL66i_ZSECIdK7SKXMmMTGsVUpzzVw4SAGJ2LOjVSpFmUiLaAAKpXlcaYcaKxbIOOiBCFd-oocV3XlXhNqtZVxrjQzKccyMzFgmWWYQmZMM6vlhHwaFr3YdWQaBRYhXk-F11PR62lCLrxGDjKeAjs8qJufRb8RCm5EXDpbSu6zQBAa52algUS7GJTlE_Le67Po8KQHQy7mygcH79om5HOQ8IuF-gXdIxLwZzwp1kjyZCSJJgjj4WHPFL0L2BfM3wwgMf3G4Q-HYT_Tt7VVrm5RRuYKa0gp1YSo0V4b_ft4BK0i0ID3VvDmv2e-JY-ZB3OEA6UTcnzXtO4dOdrb9jQcTZwGw_oNKWAq8A
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53801,53803
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RcoAL5amGFrpIUC51Yq_3YR_TpFUQaRWpQeK22pdpJGJHTn3ov2fWjxTDrVfPrPyY2XlY832L0GeiM0pUGgWRM0lAtTZBKpgNMmUEYYlITOrRyLMbcf0zmV54mhzWYWHqoX2jV8P893qYr27r2crN2oy6ObHR4moCNUfKEzLaQ09hv4ZR16Q3AZhDTA6bGXd_CM9oOp0uhzeemY74c99iBhlSJFEvEdV8_f9H5X8nJf9KPZcHj3zol-hFW2vicSN-hZ64_DU6XTRk1fdnePmAvdqe4VO8eKCxvn-DNg2Gt8ZBYSgT8dgjeqt1UeKG8niLiwxPqtJU61WOixzPIXDgMayC_FiaVV6sFa5HErCPOqW7bYbl8fmqaPla_Z1xx4vyFv24vFhOZkF7PkNgGIvvAhETrSMbhlbENFWGMmdC41hIqeYiViyLuDWgAO5A0jARzijoeExCWWYYd_E7tJ8XuTtE2CrLw1QoomMKDWqkjSWWQPGZEEWs4gP0pTOW3DQ0HBLaF29f6e0rW_sO0Lm35E7Hk2fXF4ryl2ytIalmYeZsxqmvHw1TsDbJtImUC42wdIBOvB_IBom6CwFyLHxa8UFxgL7WGv5jgV8Y1WIZ4GU8nVZP87inCZvX9MWdr8k2eGwl8WcKcCjcQfxpJ_Yr_UBc7ooKdHgqoPvkXAyQ6Plo7937EnDNmkC8dcX3j155gp7NlldzOf92_f0IPSceElL_ljpG-3dl5T6gva2tPtbb8g9kND-L
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYkBAvfCO6DWYkGC9LmzixnTx27aohxlRpReLNss8Oq0STKl0e9t9zTtKOwBu85u6UjzvfR3T3O0I-MJMnTGdREDlIg8QYCDLJbZBrkIynMoXMTyNfXMur7-n03MPk7FZ9NU37YJbD4udqWCxvmt7K9QpG2z6x0fzrBHOOTKRstLb5aI88xDMbxttCvXXCAv1y2Pa5-0U8o-l0uhhee3Q65ne_xRyjpEyjXjBqMPv_9sx_dkv-Fn5mT__jwZ-RJ13OSccty3PywBUvyMm8Ba2-O6WL-xmszSk9ofN7OOu7l2TdzvI281AU00U69pO99aqsaAt9vKFlTid1BfVqWdCyoJfoQOgYpTBOVrAsypWmTWsC9d6ncjdt0zw9W5Ydbqu_M93io7wi32bni8lF0O1pCIDz-DaQMTMmsmFoZZxkGhLuIATHwyQxQsaa55GwgAxoFiwLU-lAY-UDacJz4MLFr8l-URbuDaFWWxFmUjMTJ1ioRgYsswyT0JRpZrUYkI9bhal1C8ehsIzxOlZex6rT8YCceW3ueDyIdnOhrH6oTiMqMTzMnc1F4vNI4Bpl09xApF0I0iYDcuxtQbUTqTtXoMbShxfvHAfkU8PhPxbaBuhupgFfxsNq9TiPepx4iKFP3tqb6pzIRjG_W0BgAo_k9zuyl_SNcYUra-QRmcQqVAg5ILJnp71371PQPBsg8c4cD_5Z8pg8mk9n6vLz1ZdD8pj5yZDm79QR2b-taveW7G1s_a45mb8ARXpCCw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identifying+the+Antitumor+Effects+of+Curcumin+on+Lung+Adenocarcinoma+Using+Comprehensive+Bioinformatics+Analysis&rft.jtitle=Drug+design%2C+development+and+therapy&rft.au=Yang%2C+FR&rft.au=Li%2C+SY&rft.au=Hu%2C+X+W&rft.au=Li%2C+X+R&rft.date=2022-01-01&rft.pub=Taylor+%26+Francis+Ltd&rft.eissn=1177-8881&rft.volume=16&rft.spage=2365&rft_id=info:doi/10.2147%2FDDDT.S371420&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1177-8881&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1177-8881&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1177-8881&client=summon